Cloning And Mutagenesis Market Competitive Landscape 2024-2033

Overview and Scope

Cloning and mutagenesis refer to interrelated techniques of molecular biology that consist of making multiple identical copies of a DNA fragment, gene, or entire genome, and mutations into a DNA sequence. Cloning and mutagenesis are used to study gene function and regulation, develop new drugs and therapeutics, and develop recombinant enzymes and proteins.

Sizing and Forecast

The cloning and mutagenesis market size has grown exponentially in recent years. It will grow from $2.53 billion in 2023 to $3.05 billion in 2024 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to advancements in genetic research, increasing demand in pharmaceutical research, rise of genetic engineering in agriculture, biomedical research applications, pioneer applications in molecular biology.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $6.07 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to expanding applications in gene therapy, rising demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, application in agricultural biotechnology. Major trends in the forecast period include targeted gene editing in therapeutics, enhanced precision and specificity, customizable molecular tools, expanded applications in agriculture, ethical and regulatory considerations.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report

Segmentation & Regional Insights

The cloning and mutagenesis market covered in this report is segmented –

1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User

North America was the largest region in the cloning and mutagenesis market in 2023. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp

Major Driver Impacting Market Growth

Rising demand for genetically modified products is expected to propel the growth of the cloning and mutagenesis market going forward. Genetically modified product refers to any organism, material, or substance that has been modified by genetic engineering techniques by deliberate manipulation of an organism’s genes to introduce new traits or characteristics. Cloning is a scientific process for producing exact genetic clones for different living species, resistant to insects and plants, and in medical sciences for gene therapy, so the rising demand for genetically modified products will support the growth of the cloning and mutagenesis market. For instance, in February 2023, according to the data imparted in the annual report published by Bayar AG, a Germany-based biotechnology and pharmaceutical company, the annual sales of crop sciences and pharmaceutical segment that includes genetically modified products, has increased significantly over 2021, where the annual sales of crop sciences segment reached to $27,794.38 million in 2022, from $22,314.79 million in 2021. Therefore, the rising demand for genetically modified products is driving the growth of the cloning and mutagenesis market.

Key Industry Players

Major companies operating in the cloning and mutagenesis market report are Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

The cloning and mutagenesis market report table of contents includes:

1. Executive Summary

2. Cloning And Mutagenesis Market Characteristics

3. Cloning And Mutagenesis Market Trends And Strategies

4. Cloning And Mutagenesis Market – Macro Economic Scenario

5. Global Cloning And Mutagenesis Market Size and Growth

….

31. Global Cloning And Mutagenesis Market Competitive Benchmarking

32. Global Cloning And Mutagenesis Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

34. Cloning And Mutagenesis Market Future Outlook and Potential Analysis

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model